logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Contemporary Amperex Technology (03750) spent 321 million yuan on September 11th to repurchase 1.0186 million A-shares.

date
11/09/2025
avatar
GMT Eight
CATL (03750) announced that it will invest RMB 321 million on September 11, 2025.
Contemporary Amperex Technology (03750) announced that on September 11, 2025, it will invest 321 million yuan to repurchase 1.0186 million A-shares, with a repurchase price of 311.02-316.04 yuan per share.
Related Articles
China Stock
Huanlejia Food Group (300997.SZ): Maoxing Consulting plans to solicit quotations for transferring 1.34% of the company's shares.
HK Stock
GRAND PHARMA (00512) appears at BIOHK2025 Go Global strategy to open up the global innovative drug market.
Strategic execution capability recognized by top institutions, HCW reiterates "buy" rating for Cango Inc Sponsored ADR (CANG.US)
Huanlejia Food Group (300997.SZ): Maoxing Consulting plans to solicit quotations for transferring 1.34% of the company's shares.
China Stock
GRAND PHARMA (00512) appears at BIOHK2025 Go Global strategy to open up the global innovative drug market.
HK Stock
Strategic execution capability recognized by top institutions, HCW reiterates "buy" rating for Cango Inc Sponsored ADR (CANG.US)
RECOMMEND
Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
icon
11/09/2025
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
icon
11/09/2025
Anti-Involution Policies Deliver Results as August Price Indicators Improve
Anti-Involution Policies Deliver Results as August Price Indicators Improve
icon
11/09/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.